• Eli Lilly will acquire 381,354 ordinary shares from Richter’s treasury for approximately USD 15 million.
• The approximately USD 39.33 per-share price reflects the Budapest Stock Exchange volume-weighted average over 30 trading days immediately preceding signing.
• The investment accompanies an exclusive worldwide license to develop medicines combining Richter’s Estetrol with Lilly compounds for women’s health and cardiometabolic diseases.
• Closing is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gedeon Richter plc published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.